Hepatocellular carcinoma (HCC) is one of the most life-threatening cancers. The present study was designed to chronologically analyze the HCC chemically induced by diethylnitrosamine (DEN) in male Wistar rats during 27 weeks. DEN was given to rats in drinking water (100 mg/L) to induce HCC. In the present study, the DEN administered groups recorded dramatic results in the tumor markers, oxidative stress, lipid profile, liver function and hematological parameters at all intervals when compared to their corresponding values in the control groups. In addition, the morphometric analysis of livers of the DEN administered groups (from 9 to 27 weeks) showed gradual enlargement and several grayish white nodules and foci on the peripheral surface of the liver as the features of HCC. In conclusion, the present sequential model chronologically analyzes all steps of hepatocarcinogenesis and presents new staging system for classification of HCC that may be valuable for investigating the effects of anti-carcinogenic compounds at varying stages of hepatocarcinogenesis in vivo.
Materials and methods

Chemicals
Diethylnitrosamine was purchased from Sigma-Aldrich (St. Louis, MO, USA). DEN was given to rats in drinking water (100 mg/L). The DEN solution was prepared as a fresh solution every other day and administered to rats in dark bottles. Other chemicals and reagents were of high analytical grade and were purchased from standard commercial suppliers.
Experimental animals
A patch of 240 adult mature male Wistar albino rats obtained from the Egyptian Holding Company for Biological Products and Vaccines (VACSERA, Giza, Egypt) averaged weight 150-170 g were allowed to acclimatize in the laboratory and distributed into 16 groups of 15 rats each (8 control groups and 8 DEN administered groups) as demonstrated in Fig. (1) . Rats were maintained under standard laboratory conditions at the animal center, Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt. They were kept in a temperature-controlled environment (20-25°C) and 45%-55% relative humidity with an alternating 12 h light-dark cycle. Five rats were placed into each cage and provided with standard diet pellets and drinking DEN or tap water ad libitum.
Ethics statement
The in vivo animal experiments were conducted in accordance with the Guide for the Care and Use of Laboratory Animals (National Research Council 1996) and the use of animals was reviewed and approved by an independent ethics committee of the National D r a f t
Research Centre in Egypt. Samples were collected from each animal under anesthesia and all efforts were made to minimize suffering.
Collection of samples
At the end of the experiment, blood samples were collected from each animal from the retro-orbital venous plexus puncture. One part of the blood was collected in EDTA tubes for hematological study. The other part of the blood was left to clot at room temperature for 15 minutes. Sera were separated by centrifugation at 3000 rpm at 20°C for 15 minutes where the clear serum was obtained and kept frozen at -80°C for various biochemical analyses. After blood sampling, animals were sacrificed and livers were isolated and washed with isotonic ice-cold saline, dried on filter paper and weighed immediately.
Morphometric analysis
The nodules in nodule-bearing livers were counted and classified into three categories according to size; the nodular size in millimeter was measured by the use of an official standard caliper.
Biochemical study
A portion of each animal liver tissue was taken from all animal groups. Each tissue was homogenized in ice-cold Tris-HCl lysis buffer, pH 7.4 containing 1% protease inhibitor cocktail (Cell Signaling Technology, Inc., MA, USA) using Potter-Elvehjem rotor-stator Homogenizer, fitted with a Teflon pestle (Omni International, Kennesaw, GA, USA). The tissue homogenates were centrifuged under cooling at 3000 rpm for 20 min., supernatants were subsequently aliquoted and stored at -80°C until used for determination of hepatic oxidative stress parameters. (Aebi 1984) levels were estimated using kits from bio-diagnostic Co., for research kits, Egypt.
Liver function tests
The serum levels of transaminases, AST and ALT (Bergmeyer et al. 1986 ), alkaline France. The globulin was determined by subtracting the albumin from the TP for each rat.
Lipid profile
The serum lipid profile levels of triglycerides (TG 
Hematological parameters
The erythrocyte count, total and differential leukocyte count, platelet count, hematocrite percentage, and hemoglobin concentration were estimated in the blood by using a CBC analyzer (Sino thinker. sk9000, U.S).
Western blot assessments
The Western blot assessments of glypican-3 and Golgi protein 73 were conducted according to the procedure described by Elsadek et al. (2017).
Statistical analysis
The statistical analysis of the results was performed by using statistical package for social sciences SPSS/PC computer program (version 19) . All values were expressed as mean±SE and the results were analyzed using one-way analysis of variance (ANOVA) test followed by least significant difference (LSD) test for multiple comparisons.
Differences were considered statistically significant at p<0.05.
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Results
The body weight and the mortality rate
The change in body weight during the period of the experiment (27 weeks) in the control and diethylnitrosamine (DEN) administered groups illustrated in Fig. (2) and demonstrated that, in the first weeks following DEN administration, the rats began to show a slow growth and along with the DEN administration, the mean weight decreased gradually as compared to the control rats. The marked decrease in body weight was recorded start from week 12 to week 18 of DEN administration. The body weight became nearly steady with no marked changes from week 18 to the end of the experiment. The present study showed no mortality in the control groups during the experiment (27 weeks). On the other hand, the mortality rate of DEN administered groups was 0%, 0%, 6.67%, 13.33%, 20.00%, 33.33%, 46.67% and 60.00% during 6, 9, 12, 15, 18, 21, 24 and 27 weeks, respectively.
The liver weight
The DEN administered groups at all intervals recorded a significant decrease (p<0.05) of the final body weight and body weight gain when compared to their corresponding values in the control groups. On the contrary, a significant increase (p<0.05) in liver weight and relative liver weight were recorded at all DEN administered intervals except for the interval of 6 weeks, which recorded a significant decrease (p<0.05) when compared to their corresponding values in the control groups (Table 1) .
Morphometric analysis of the liver
The morphometric analysis of the liver in the control groups reveals smooth surface with normal morphology, without any sub capsular nodules through the 27-week experimental period. Similarly, the livers in the DEN administered group at the end of 6 weeks also, appeared with smooth surface without any nodules. On the contrary, the macroscopic gross appearance of livers in the DEN administered groups (from 9 to 27 weeks interval) showing gradual enlargement and several grayish white nodules and foci on the peripheral surface of the liver as the features of HCC (Fig. 3) .
The incidence of nodules in DEN administered groups were zero%, 30%, 70%, 80% at the end of 6, 9, 12 and 15 weeks, respectively, and 100% at the end of 18, 21, 24 and 27 weeks. The average number of nodules at nodule-bearing liver in DEN administered groups showed an insignificant increase at the first three time points (6, 9 and 12 weeks) as compared to each others. On the other hand, the other five time points (15, 18, 21, 24 and 27 weeks) recorded a significant increase (p<0.05) in the average number of nodules at nodule-bearing livers when compared to each others in an ascending manner and as any of them being compared to any of the first three time points (Table 1 ). In the present study, the number of nodules with size less than 1 mm in diameter at nodule-bearing liver in DEN administered groups recorded a significant increase (p<0.05) in an ascending manner. Moreover, the time points 18, 21, 24 and 27 weeks recorded a significant increase (p<0.05) in the number of hypoplastic nodules with size from 1-3 mm in diameter at nodule-bearing livers when compared to each others in an ascending manner.
Furthermore, the time points 21, 24 and 27 weeks recorded a significant increase (p<0.05) in the number of hyperplastic (neoplastic) nodules with size more than 3 mm in D r a f t diameter at nodule-bearing livers when compared to each others in an ascending manner (Table 1) .
Oxidative stress parameters
The DEN administered groups recorded a significant increase (p<0.05) in TBARS and AOPPs throughout the experimental period when compared to their corresponding control values, except for the TBARS at the 6 weeks it recorded insignificant change as compared to the corresponding value in the control group. In addition, the DEN administered groups recorded a significant decrease (p<0.05) in NO, SOD, CAT and GSH at the end of 6, 9, 12, 15, 18, 21, 24 and 27 weeks respectively, when compared to their corresponding values in the control groups (Table 2) .
Liver function tests
The DEN administered groups recorded a significant increase (p<0.05) in AST, ALT, ALP, TBIL, TP & globulin in contrast to a significant decrease (p<0.05) in albumin & A/G ratio at the end of 6, 9, 12, 15, 18, 21, 24 and 27 weeks respectively, when compared to their corresponding values in the control groups. Except for TBIL at 6 weeks, it recorded an insignificant increase as compared to the corresponding control value (Table   3 ).
Hepatocellular carcinoma tumor markers
The DEN administered groups recorded a significant increase (p<0.001) in GGT, AFU, AFP, AFP-L3 & GP73 at the end of 6, 9, 12, 15, 18, 21, 24 and 27 weeks respectively, in DEN administered groups when compared to their corresponding values D r a f t 11 in the control groups. In addition, the DEN administered groups recorded an insignificant increase in GPC3 in the first four time intervals (6, 9, 12 &15 weeks) and a significant increase (p<0.001) throughout the remaining experimental periods (18, 21, 25 & 27 weeks) when compared to their corresponding control values. However, the DEN administered groups recorded an insignificant increase in VEGF in the first two time intervals (6 & 9 weeks) and a significant increase (p<0.001) throughout the remaining experimental periods (12, 15, 18, 21, 24 & 27 weeks) when compared to their corresponding control values (Table 4 and Fig. 4) . Moreover, the DEN administered groups recorded over-expressions of GPC3 and GP73 in the liver tissue homogenates as indicated by the Western blot assessments (Fig. 5) .
Lipid profile
The DEN administered groups recorded a significant increase (p<0.05) in TG, TC, LDL-C, TG/HDL-C, TC/HDL-C & LDL-C/HDL-C risk ratios and a significant decrease (p<0.05) in HDL-C at the end of 6, 9, 12, 15, 18, 21, 24 and 27 weeks respectively when compared to their corresponding values in the control groups (Table 5) .
Hematological parameters
The DEN administered groups recorded a significant decrease (p<0.05) in the RBC count, Hb concentration, Hct percentage, platelet count, WBC count and lymphocyte percentage at the end of 6, 9, 12, 15, 18, 21, 24 and 27 weeks respectively, when compared to their corresponding control values. Except for lymphocyte percentage at 6 weeks, it recorded insignificant change as compared to the corresponding values in the control groups. On the other hand, the DEN administered groups recorded a significant D r a f t 12 increase (p<0.05) in neutrophil percentage and monocyte percentage at the end of 6, 9, 12, 15, 18, 21, 24 and 27 weeks, respectively, when compared to their corresponding control values, except for the neutrophils percentage at 6 weeks and monocytes percentage at 6 and 9 weeks they recorded insignificant change as compared to the corresponding values in the control groups (Table 6 ).
Hepatocelluar carcinoma staging
Bashandy, Mansour & Fathy (BMF) staging system in the present study includes an assessment of liver disease (HCC) and tumor extension through physical, oxidative stress, hematological, biochemical and specific tumor marker parameters for HCC following treatment with DEN. The BMF staging system might be an appropriate classification system for HCC induced in rat model using diethylnitrosamine. In addition, based on the intensive investigation of the current data, the BMF staging system is classified into an early (6-12 weeks), intermediate (15-18 weeks), advanced (18-21 weeks) and late stages (24-27 weeks) of the disease. All stages recorded a significance difference (p<0.05) in all tested parameters from each other's and as any of them being compared to the control rats. The notable feature of the BMF staging system is the assignment of treatment recommendations for each stage based on the best treatment options currently available, and this system has been updated according to the results of our investigations that have incorporated strong evidence. The BMF staging system and treatment allocations are summarized in (Table 7) .
Discussion
Hepatocellular carcinoma is a highly heterogeneous disease with highly variable etiological factors, including viruses with a DNA (HBV) or RNA (HCV) genome, chemicals (diethylnitrosamine and aflatoxins), and inborn and acquired metabolic diseases. In addition, HCC undergoes a dynamic process changing morphological features as it advances. Therefore, mechanisms of hepatocellular carcinogenesis may vary depending on different factors. The most prominent ones including loss of cell cycle control, escape from senescence control, resistance to cell death, phenotypic plasticity,
motility, invasion, and metastasis (Brian 2016).
A correlation was noted between the raised incidence of HCC and obesity. 
D r a f t
In agreement with the present study, oxidative stress can be considered a key event in the progression from fatty liver to steatohepatitis. An increase in the production of ROS and RNS, mainly derived from mitochondrial free fatty acids oxidation, leading to dyslipidemia and increased supply of free fatty acids to the liver that combined with Liver cancer induction and progression has been extensively examined in the rodent. The experimental schedules of diethylnitrosamine (DEN) administered and control (C) groups during 27 weeks.
76x26mm (600 x 600 DPI) D r a f t
The chronological changes of body weight during 27 weeks in the control and diethylnitrosamine (DEN) administered groups. 116x62mm (300 x 300 DPI)
